Deep clinical and biological phenotyping of the preterm birth and small for gestational age syndromes: The INTERBIO-21st Newborn Case-Control Study protocol

Stephen Kennedy, César G. Victora, Rachel Craik, Stephen Ash, Fernando C. Barros, Hellen C. Barsosio, James A. Berkley, Maria Carvalho, Michelle Fernandes, Leila Cheikh Ismail, Ann Lambert, Cecilia M. Lindgren, Rose McGready, Shama Munim, Christoffer Nellåker, J. Alison Noble, Shane A. Norris, François Nosten, Eric O. Ohuma, Aris T. Papageorghiou, Alan Stein, William Stones, Chrystelle O.o. Tshivuila-Matala, Eleonora Staines Urias, Manu Vatish, Katharina Wulff, Ghulam Zainab, Krina T. Zondervan, Ricardo Uauy, Zulfiqar A Bhutta, José R. VillarGates 2019 · DOI

TL;DR

This paper outlines the INTERBIO-21st Newborn Case-Control Study, a large-scale international effort to deeply phenotype preterm birth and small for gestational age (SGA) syndromes. By integrating clinical, biological, and environmental data, the study aims to move beyond broad classifications to a more functional understanding of these complex conditions, paving the way for improved diagnostics and interventions.

What Problem Does This Paper Address?

Preterm birth and small for gestational age (SGA) are major contributors to infant mortality and long-term health issues. However, current classifications of these conditions are often broad and non-specific, hindering our ability to understand their underlying mechanisms and develop targeted interventions. The INTERGROWTH-21st project previously established international growth standards, but Phase II, the INTERBIO-21st study, aims to delve deeper. It tackles the challenge of understanding the complex interplay of environmental exposures, clinical conditions, and nutritional factors that contribute to these syndromes, moving towards a more mechanistic and functional classification.

Methods

The INTERBIO-21st Newborn Case-Control Study employs a "deep phenotyping" approach. This involves collecting a comprehensive array of data, including:

  • Longitudinal Clinical Data: Detailed information on pregnancy, delivery, and infant health.
  • Growth Data: Standardized measurements of weight, length, and head circumference.
  • Biological Samples: Maternal blood, umbilical cord blood, placental tissue, maternal feces, and infant buccal swabs are collected for future nutritional, biochemical, omic, and histological analyses.
  • Neurodevelopmental Assessment: At 1 and 2 years of age, infants undergo assessments of cognition, language, motor skills, behavior, sleep patterns, and visual acuity using the INTERGROWTH-21st Neurodevelopment Package.
  • Body Composition: In a subset of infants, body composition is assessed using air displacement plethysmography.

The study design utilizes a case-control approach, with specific definitions for preterm birth and SGA cases and controls, aiming for a 2:1 ratio of controls to cases. Rigorous standardization procedures, quality control measures, and a dedicated data management system are in place to ensure data integrity across multiple international sites.

Datasets

The study leverages data collected between 2012 and 2018 from seven sites across Brazil, Kenya, Pakistan, South Africa, Thailand, and the UK. This includes:

  • Longitudinal clinical data from mothers and infants.
  • Biological samples (maternal blood, cord blood, placenta, maternal feces, infant buccal swabs).
  • Anthropometric measurements of newborns.
  • Neurodevelopmental assessment data at 1 and 2 years of age.
  • Newborn body composition data from two sites.

This extensive dataset builds upon the foundation of the INTERGROWTH-21st Project, which previously generated international standards for fetal and childhood growth.

Key Insights and Ideas

  • Moving Beyond Broad Classifications: The core idea is that current broad definitions of preterm birth and SGA are insufficient. By collecting detailed, multi-faceted data, the study aims to identify distinct underlying mechanisms and functional classifications for these syndromes.
  • The Power of "Deep Phenotyping": The study emphasizes integrating diverse data types (clinical, biological, environmental) to gain a holistic understanding of complex health conditions, rather than relying on single markers.
  • Environmental Influences are Key: A central hypothesis is that environmental exposures (nutrition, infections, pregnancy complications) play a crucial role in shaping fetal growth and neurodevelopment, and the study is designed to explore these interactions.
  • Epigenetics as a Potential Mediator: The paper highlights the growing evidence that epigenetic patterns, particularly in the placenta, can reflect intrauterine exposures and may mediate the link between environmental factors and adverse outcomes.
  • A Unique Resource for Future Research: The comprehensive dataset and biorepository assembled by this study are expected to be invaluable for future research into the complex etiologies of preterm birth and SGA.

Key Results

As this paper describes the study protocol, no results are presented. However, the study is designed to generate insights into:

  • The mechanisms underlying preterm birth and SGA.
  • The influence of environmental exposures, clinical conditions, and nutrition on growth and neurodevelopment.
  • Potential functional classifications for these syndromes.
  • The role of epigenetics in mediating adverse pregnancy outcomes.

Limitations and Future Work

  • Definition of Preterm Birth: One reviewer raised a concern about the study's definition of preterm birth as delivery prior to 38 weeks, which differs from the commonly accepted definition of prior to 37 weeks. The authors' justification based on neonatal outcome was questioned, with the reviewer suggesting this could lead to overlap and make it harder to identify distinct mechanistic differences.
  • Exclusion of Post-Term Pregnancies: The study did not include a cohort of post-term pregnancies, which a reviewer suggested could have provided valuable insights into labor onset mechanisms.
  • Nutritional Analysis Details: The paper mentions "nutritional analysis" but lacks specific details on whether this includes metabolomic analysis, food diaries, or breast milk analysis, which are crucial for understanding growth and neurodevelopment.
  • Ancillary Study Sample Sizes: The sample sizes for ancillary studies (body composition, postnatal follow-up) are not explicitly stated, nor is it clear if these studies are for all enrollees or a subset.

Future work will involve analyzing the collected data to address the study's objectives, aiming to enhance medical knowledge and provide new insights into environmental influences on human growth and neurodevelopment. The study's findings will be disseminated widely through various channels.

Summary updated

Abstract

<b>Background:</b> INTERBIO-21 <sup>st</sup> is Phase II of the INTERGROWTH-21 <sup>st</sup> Project, the population-based, research initiative involving nearly 70,000 mothers and babies worldwide coordinated by Oxford University and performed by a multidisciplinary network of more than 400 healthcare professionals and scientists from 35 institutions in 21 countries worldwide. Phase I, conducted 2008-2015, consisted of nine complementary studies designed to describe optimal human growth and neurodevelopment, based conceptually on the WHO prescriptive approach. The studies generated a set of international standards for monitoring growth and neurodevelopment, which complement the existing WHO Child Growth Standards. Phase II aims to improve the functional classification of the highly heterogenous preterm birth and fetal growth restriction syndromes through a better understanding of how environmental exposures, clinical conditions and nutrition influence patterns of human growth from conception to childhood, as well as specific neurodevelopmental domains and associated behaviors at 2 years of age. <b>Methods:</b> In the INTERBIO-21 <sup>st</sup> Newborn Case-Control Study, a major component of Phase II, our objective is to investigate the mechanisms potentially responsible for preterm birth and small for gestational age and their interactions, using deep phenotyping of clinical, growth and epidemiological data and associated nutritional, biochemical, omic and histological profiles. Here we describe the study sites, population characteristics, study design, methodology and standardization procedures for the collection of longitudinal clinical data and biological samples (maternal blood, umbilical cord blood, placental tissue, maternal feces and infant buccal swabs) for the study that was conducted between 2012 and 2018 in Brazil, Kenya, Pakistan, South Africa, Thailand and the UK. <b>Discussion:</b> Our study provides a unique resource for the planned analyses given the range of potentially disadvantageous exposures (including poor nutrition, pregnancy complications and infections) in geographically diverse populations worldwide. The study should enhance current medical knowledge and provide new insights into environmental influences on human growth and neurodevelopment.
BibTeX
@inproceedings{kennedy2019deep,
  author = {Stephen Kennedy and César G. Victora and Rachel Craik and Stephen Ash and Fernando C. Barros and Hellen C. Barsosio and James A. Berkley and Maria Carvalho and Michelle Fernandes and Leila Cheikh Ismail and Ann Lambert and Cecilia M. Lindgren and Rose McGready and Shama Munim and Christoffer Nellåker and J. Alison Noble and Shane A. Norris and François Nosten and Eric O. Ohuma and Aris T. Papageorghiou and Alan Stein and William Stones and Chrystelle O.O. Tshivuila-Matala and Eleonora Staines Urias and Manu Vatish and Katharina Wulff and Ghulam Zainab and Krina T. Zondervan and Ricardo Uauy and Zulfiqar A Bhutta and José R. Villar},
  title = {{Deep clinical and biological phenotyping of the preterm birth and small for gestational age syndromes: The INTERBIO-21st Newborn Case-Control Study protocol}},
  booktitle = {Gates},
  year = {2019},
  doi = {10.12688/gatesopenres.12869.2},
}
Figure